AZN vs. CVS: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AZN and CVS, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AZN dominates in value with a market cap of 432.07 billion USD, eclipsing CVS’s 78.57 billion USD by roughly 5.50×.
CVS carries a higher beta at 0.60, indicating it’s more sensitive to market moves, while AZN remains steadier at 0.18.
AZN trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while CVS remains a standard domestic listing.
| Symbol | AZN | CVS |
|---|---|---|
| Company Name | AstraZeneca PLC | CVS Health Corporation |
| Country | GB | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | Mr. J. David Joyner CEBS |
| Price | 69.68 USD | 62.11 USD |
| Market Cap | 432.07 billion USD | 78.57 billion USD |
| Beta | 0.18 | 0.60 |
| Exchange | NASDAQ | NYSE |
| IPO Date | May 12, 1993 | November 20, 1996 |
| ADR | Yes | No |
Performance Comparison
This chart compares the performance of AZN and CVS over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AZN and CVS, please refer to the table below.
| Symbol | AZN | CVS |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 27.82 | 14.83 |
| Forward PEG Ratio (TTM) | 2.50 | 1.27 |
| Price-to-Sales Ratio (P/S, TTM) | 3.93 | 0.21 |
| Price-to-Book Ratio (P/B, TTM) | 5.27 | 1.02 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 22.35 | 13.23 |
| EV-to-EBITDA (TTM) | 13.69 | 10.98 |
| EV-to-Sales (TTM) | 4.42 | 0.40 |
| EV-to-Free Cash Flow (TTM) | 25.09 | 25.20 |
Dividend Comparison
CVS stands out with a 4.28% dividend yield—around 208% above AZN’s 1.39%—highlighting its emphasis on generous payouts.
| Symbol | AZN | CVS |
|---|---|---|
| Dividend Yield (TTM) | 1.39% | 4.28% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AZN and CVS, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- With current ratios of 0.90 and 0.82, both AZN and CVS have less current assets than short-term liabilities, which could strain their working capital and force reliance on additional financing.
- Both AZN (quick ratio 0.70) and CVS (quick ratio 0.63) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
| Symbol | AZN | CVS |
|---|---|---|
| Current Ratio (TTM) | 0.90 | 0.82 |
| Quick Ratio (TTM) | 0.70 | 0.63 |
| Debt-to-Equity Ratio (TTM) | 0.77 | 1.06 |
| Debt-to-Assets Ratio (TTM) | 0.30 | 0.32 |
| Interest Coverage Ratio (TTM) | 7.95 | 3.18 |